News Summary

• More than 300 clinicians, researchers, and decision makers from across Canada gathered in Toronto on November 18–19 for the fourth annual bioMérieux Canada Antimicrobial Resistance (AMR) Symposium.
• The two-day event showcased the latest science, innovations, and public-health strategies aimed at slowing the spread of drug-resistant infections.
• In Canada, AMR already contributes to an estimated 13,700 deaths each year and could cost the economy $7.6 billion annually by 2050 if left unchecked.